Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study
Male
Nurses
Logistic regression
Infection control
Social Distancing
Pediatrics
Infectious Disease Transmission, Professional-to-Patient
Cohort Studies
Engineering
0302 clinical medicine
Risk Factors
Psychological intervention
Observational study
Internal medicine
11 Medical and Health Sciences
Aged, 80 and over
Psychiatry
Cross Infection
Airborne Transmission of Respiratory Viruses
Modeling the Dynamics of COVID-19 Pandemic
R
Cohort
Middle Aged
Hospitals
3. Good health
Community-Acquired Infections
Hospitalization
Serology
Oncology
Modeling and Simulation
Physical Sciences
Impact of COVID-19 on Cancer Patients and Care
Medicine
Emergency medicine
Female
Cohort study
Research Article
Adult
Pulmonary and Respiratory Medicine
570
Infectious Disease Transmission, Patient-to-Professional
Health Personnel
Immunology
610
03 medical and health sciences
Oxford COVID infection review team
General & Internal Medicine
616
Health Sciences
FOS: Mathematics
Humans
Intensive care medicine
Antibody
Aged
Infection Control
SARS-CoV-2
FOS: Clinical medicine
COVID-19
Transmission (telecommunications)
Electrical engineering
Mathematics
DOI:
10.1371/journal.pmed.1003816
Publication Date:
2021-10-13T00:26:22Z
AUTHORS (11)
ABSTRACT
Background
Nosocomial spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been widely reported, but the transmission pathways among patients and healthcare workers (HCWs) are unclear. Identifying the risk factors and drivers for these nosocomial transmissions is critical for infection prevention and control interventions. The main aim of our study was to quantify the relative importance of different transmission pathways of SARS-CoV-2 in the hospital setting.
Methods and findings
This is an observational cohort study using data from 4 teaching hospitals in Oxfordshire, United Kingdom, from January to October 2020. Associations between infectious SARS-CoV-2 individuals and infection risk were quantified using logistic, generalised additive and linear mixed models. Cases were classified as community- or hospital-acquired using likely incubation periods of 3 to 7 days. Of 66,184 patients who were hospitalised during the study period, 920 had a positive SARS-CoV-2 PCR test within the same period (1.4%). The mean age was 67.9 (±20.7) years, 49.2% were females, and 68.5% were from the white ethnic group. Out of these, 571 patients had their first positive PCR tests while hospitalised (62.1%), and 97 of these occurred at least 7 days after admission (10.5%). Among the 5,596 HCWs, 615 (11.0%) tested positive during the study period using PCR or serological tests. The mean age was 39.5 (±11.1) years, 78.9% were females, and 49.8% were nurses. For susceptible patients, 1 day in the same ward with another patient with hospital-acquired SARS-CoV-2 was associated with an additional 7.5 infections per 1,000 susceptible patients (95% credible interval (CrI) 5.5 to 9.5/1,000 susceptible patients/day) per day. Exposure to an infectious patient with community-acquired Coronavirus Disease 2019 (COVID-19) or to an infectious HCW was associated with substantially lower infection risks (2.0/1,000 susceptible patients/day, 95% CrI 1.6 to 2.2). As for HCW infections, exposure to an infectious patient with hospital-acquired SARS-CoV-2 or to an infectious HCW were both associated with an additional 0.8 infection per 1,000 susceptible HCWs per day (95% CrI 0.3 to 1.6 and 0.6 to 1.0, respectively). Exposure to an infectious patient with community-acquired SARS-CoV-2 was associated with less than half this risk (0.2/1,000 susceptible HCWs/day, 95% CrI 0.2 to 0.2). These assumptions were tested in sensitivity analysis, which showed broadly similar results. The main limitations were that the symptom onset dates and HCW absence days were not available.
Conclusions
In this study, we observed that exposure to patients with hospital-acquired SARS-CoV-2 is associated with a substantial infection risk to both HCWs and other hospitalised patients. Infection control measures to limit nosocomial transmission must be optimised to protect both staff and patients from SARS-CoV-2 infection.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (52)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....